1468 related articles for article (PubMed ID: 12778484)
21. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.
Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P
Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012
[TBL] [Abstract][Full Text] [Related]
22. CD8 T cells expressing killer Ig-like receptors and NKG2A are present in cord blood and express a more naïve phenotype than their counterparts in adult blood.
Warren HS; Rana PM; Rieger DT; Hewitt KA; Dahlstrom JE; Kent AL
J Leukoc Biol; 2006 Jun; 79(6):1252-9. PubMed ID: 16574769
[TBL] [Abstract][Full Text] [Related]
23. Critical role of Qa1b in the protection of mature dendritic cells from NK cell-mediated killing.
Persson CM; Assarsson E; Vahlne G; Brodin P; Chambers BJ
Scand J Immunol; 2008 Jan; 67(1):30-6. PubMed ID: 18028286
[TBL] [Abstract][Full Text] [Related]
24. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
Söderström K; Corliss B; Lanier LL; Phillips JH
J Immunol; 1997 Aug; 159(3):1072-5. PubMed ID: 9233599
[TBL] [Abstract][Full Text] [Related]
25. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors.
Sivori S; Cantoni C; Parolini S; Marcenaro E; Conte R; Moretta L; Moretta A
Eur J Immunol; 2003 Dec; 33(12):3439-47. PubMed ID: 14635054
[TBL] [Abstract][Full Text] [Related]
26. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells.
Pietra G; Romagnani C; Mazzarino P; Millo E; Moretta L; Mingari MC
Eur J Immunol; 2003 Dec; 33(12):3427-32. PubMed ID: 14635052
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
29. Computational modeling of human natural killer cell development suggests a selection process regulating coexpression of KIR with CD94/NKG2A.
Salmon-Divon M; Höglund P; Johansson MH; Johansson S; Mehr R
Mol Immunol; 2005 Feb; 42(4):397-403. PubMed ID: 15607790
[TBL] [Abstract][Full Text] [Related]
30. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
Tanaka J; Toubai T; Miura Y; Tsutsumi Y; Kato N; Umehara S; Toyoshima N; Ohta S; Asaka M; Imamura M
Transplant Proc; 2004 Oct; 36(8):2511-2. PubMed ID: 15561299
[TBL] [Abstract][Full Text] [Related]
32. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
[TBL] [Abstract][Full Text] [Related]
33. Expression of NK cell receptors on decidual T cells in human pregnancy.
Tilburgs T; van der Mast BJ; Nagtzaam NM; Roelen DL; Scherjon SA; Claas FH
J Reprod Immunol; 2009 Jun; 80(1-2):22-32. PubMed ID: 19394706
[TBL] [Abstract][Full Text] [Related]
34. How do NK cells sense the expression of HLA-G class Ib molecules?
López-Botet M; Navarro F; Llano M
Semin Cancer Biol; 1999 Feb; 9(1):19-26. PubMed ID: 10092547
[TBL] [Abstract][Full Text] [Related]
35. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
Lin Chua H; Brahmi Z
Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268
[TBL] [Abstract][Full Text] [Related]
36. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
[TBL] [Abstract][Full Text] [Related]
37. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
Pietra G; Semino C; Cagnoni F; Boni L; Cangemi G; Frumento G; Melioli G
J Med Virol; 2000 Nov; 62(3):354-63. PubMed ID: 11055246
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals.
Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R
Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286
[TBL] [Abstract][Full Text] [Related]
40. The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase.
Chen XY; Zhuang YL; Li L; Zhang WW; Huang LL
Fertil Steril; 2010 May; 93(8):2615-20. PubMed ID: 19880106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
